Cargando…
Cilia at the Crossroads of Tumor Treating Fields and Chemotherapy
Glioblastoma (GBM), the most common and lethal primary brain tumor in adults, requires multi-treatment intervention which unfortunately barely shifts the needle in overall survival. The treatment options after diagnosis and surgical resection (if possible) include irradiation, temozolomide (TMZ) che...
Autores principales: | Deleyrolle, Loic P., Sarkisian, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233696/ http://dx.doi.org/10.1159/000529193 |
Ejemplares similares
-
Neurochemical Profile of BRAF(V600E)/Akt(T308D/S473D) Mouse Gangliogliomas Reveals Impaired GABAergic System Inhibition
por: Kyriazi, Maria, et al.
Publicado: (2022) -
Tumor Treating Fields Suppression of Ciliogenesis Enhances Temozolomide Toxicity
por: Shi, Ping, et al.
Publicado: (2022) -
Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review
por: Lehner, Kurt R., et al.
Publicado: (2022) -
Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Associates with Huntingtin Protein and Promotes Its Atypical Ubiquitination to Enhance Aggregate Formation
por: Zucchelli, Silvia, et al.
Publicado: (2011) -
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Signaling and Cell Death in the Immature Central Nervous System after Hypoxia-Ischemia and Inflammation
por: Kichev, Anton, et al.
Publicado: (2014)